Published in Medical Letter on the CDC and FDA, August 15th, 2004
The Mylan product is currently available to the trade in 0.025 mg, 0.050 mg, 0.075 mg, 0.088 mg, 0.1 mg, 0.112 mg, 0.125 mg, 0.150 mg, 0.175 mg, 0.2 mg and 0.3 mg strengths.
Mylan is the first company to offer Levothyroxine Sodium Tablets as AB-rated to Levoxyl, Unithroid and Synthroid.
Mylan Laboratories Inc. is a pharmaceutical company...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.